Skip to content
FDA cuts back on Accelerated Approval pathway in 2022
The Accelerated Approval (AA) pathway, one of the U.S. Food and Drug Administration’s ...
Read More
Common bacterial infections behind every eight death in the world in 2019, study says
One in eight global deaths in 2019 was caused by common bacterial infections, ...
Read More
2022 midterms recap: what happened and what the results mean for biotech
The 2022 midterms are officially behind us – so, what happened, and what ...
Read More
Spending bill should require FDA to clarify genome editing policy, lawmakers say
The 2023 appropriations legislation currently under debate in Congress should require the U.S. ...
Read More
Moderna’s personalized mRNA melanoma vaccine achieves positive results
In a development hailed as a possible cancer breakthrough, Moderna announced Tuesday that its ...
Read More
COVID-19 vaccines two years later: 3 million lives and a trillion dollars saved
When nurse Sandra Lindsay received the first dose of the COVID-19 vaccine in ...
Read More
EDITORS' CHOICE
Congressional commission urges support in U.S.-China competition for biotech dominance
Maintaining biotechnology superiority is essential to the U.S. economy and national security, and it must be supported with strategic federal funding that leans into America’s ...
Read More
LATEST NEWS
Federal Policy
Nkarta’s Hastings discusses environment for biotech funding in Endpoints panel
Speaking on a recent Endpoints News panel, Nkarta CEO Paul Hastings discussed the impact of regulatory uncertainty and federal funding cuts on the investment climate ...
Federal Policy
U.S. leadership in rare disease drugs at risk, BIO expert tells Orphan Drug Congress
America has long been the global leader in rare disease drug development but this leadership is at risk unless Congress protects key incentives In 1983, ...
Agriculture
BIO applauds reintroduction of two bills aimed at patent reform
The May 1 reintroduction of two bills designed to strengthen the certainty of U.S. patents earned praise from the Biotechnology Innovation Organization (BIO). The Patent ...
Federal Policy
BIO report outlines use of NAMs to reduce animal testing
Safeguarding human health during clinical research is critically important, but biotechnology has shown that this does not always have to mean using animals to test ...
Health
Q1 roundup of state health policy impacting biotech
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move into the mid-year, the Biotechnology ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
Q1 roundup of state health policy impacting biotech
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move ...
Read More
International
Bio's View
BIO campaign urges: ‘Invest in America. Vaccinate’
Now that vaccines have all but eliminated smallpox, measles, polio, and other childhood scourges in the U.S., it seems easy ...
Read More
